Related Experiment Video

Updated: Jul 11, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Exploiting the convergence of embryonic and tumorigenic signaling pathways to develop new therapeutic targets

Daniel E Abbott1, Lynne-Marie Postovit, Elisabeth A Seftor

  • 1Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA.

Stem Cell Reviews
|September 18, 2007
PubMed

Insights

Embryonic stem cells share similarities with cancer cells, offering potential therapeutic targets. Their microenvironment can reprogram cancer cells toward a benign phenotype, paving the way for novel differentiation therapies.

Area of Science:

  • Stem cell biology
  • Cancer biology
  • Developmental biology

Background:

  • Embryonic stem cells (ESCs) and cancer cells exhibit striking similarities in self-renewal and epigenetic plasticity.
  • Both cell types can alter their microenvironment and create phenotypically diverse cell populations.

Purpose of the Study:

  • To explore the convergence of embryonic and tumorigenic signaling pathways.
  • To investigate the potential of ESCs and their secreted factors in reprogramming cancer cells.
  • To highlight implications for developing novel cancer differentiation therapies.

Main Methods:

  • Comparative analysis of molecular signatures between ESCs and cancer cells.
  • Review of evidence demonstrating the inductive influence of ESCs on cancer cell reprogramming.
  • Exploration of signaling pathway convergence.

Main Results:

  • Identification of shared molecular mechanisms between ESCs and cancer cells, including self-renewal and epigenetic regulation.
  • Evidence suggests ESCs and their microenvironment can induce a more benign phenotype in cancer cells.
  • Convergence of embryonic and cancer signaling pathways offers new therapeutic avenues.

Conclusions:

  • Understanding the shared biology of ESCs and cancer cells can reveal novel therapeutic targets.
  • ESCs and their microenvironment possess the potential to reprogram cancer cells, supporting differentiation therapy.
  • Further research into ESC-cancer cell interactions may revolutionize cancer treatment strategies.

More Related Videos

Optogenetic Signaling Activation in Zebrafish Embryos07:18

Optogenetic Signaling Activation in Zebrafish Embryos

Published on: October 27, 2023

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...